International journal of epidemiology 2007-04

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).

Related Questions

Would you recommend switching from an integrase strand transfer inhibitor-based regimen to a different antiretroviral regimen, or would you instead add weight loss medications for a person with HIV experiencing weight gain that has not improved with lifestyle changes?

Infectious Disease · University of Texas Southwestern Medical School

The data about weight gain attributable to integrase strand inhibitors is actually a bit controversial. Multiple studies have raised the concern for increased weight gain in patients treated with second-generation INSTIs (ADVANCE, NA-ACCORD), while others indicate more of an impact of tenofovir alaf...